Connecticut General Statutes 21a-286 – Agreements for distribution and administration of opioid antagonists. Regulations
(a) For purposes of this section:
Terms Used In Connecticut General Statutes 21a-286
- Administer: means the direct application of a controlled substance, whether by injection, inhalation, ingestion or any other means, to the body of a patient or research subject by: (A) A practitioner, or, in his presence, by his authorized agent, or (B) the patient or research subject at the direction and in the presence of the practitioner, or (C) a nurse or intern under the direction and supervision of a practitioner. See Connecticut General Statutes 21a-240
- Damages: Money paid by defendants to successful plaintiffs in civil cases to compensate the plaintiffs for their injuries.
- Distribute: means to deliver other than by administering or dispensing a controlled substance. See Connecticut General Statutes 21a-240
- Pharmacist: means a person authorized by law to practice pharmacy pursuant to §. See Connecticut General Statutes 21a-240
- Practitioner: means : (A) A physician, dentist, veterinarian, podiatrist, scientific investigator or other person licensed, registered or otherwise permitted to distribute, dispense, conduct research with respect to or to administer a controlled substance in the course of professional practice or research in this state. See Connecticut General Statutes 21a-240
- Prescribe: means order or designate a remedy or any preparation containing controlled substances. See Connecticut General Statutes 21a-240
(1) “Opioid antagonist” shall have the meaning set forth in § 17a-714a.
(2) “Prescribing practitioner” shall have the meaning set forth in § 20-14c.
(3) “Pharmacist” shall have the meaning set forth in § 20-609a.
(b) A prescribing practitioner or a pharmacist certified to prescribe naloxone pursuant to § 20-633c may enter into an agreement with a law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education related to the distribution and administration of an opioid antagonist for the reversal of an opioid overdose. The prescribing practitioner or pharmacist shall provide training to persons who will distribute or administer the opioid antagonist pursuant to the terms of the agreement. Persons other than the prescribing practitioner or pharmacist shall receive training in the distribution or administration of opioid antagonists prior to distributing or administering an opioid antagonist. The agreement shall address the storage, handling, labeling, recalls and recordkeeping of opioid antagonists by the law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education which is party to the agreement.
(c) A prescribing practitioner or pharmacist who enters into an agreement pursuant to subsection (b) of this section shall not be liable for damages in a civil action or subject to administrative or criminal prosecution for the administration or dispensing of an opioid antagonist by such law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education.
(d) The Commissioner of Consumer Protection may adopt regulations, in accordance with the provisions of chapter 54, to implement the provisions of this section.